Here you can find publicly accessible information about our medicinal products. The overview is not exhaustive.
If you are a healthcare professional and have a question about one of Lucane Pharma’s products, please send us a contact request via the contact page. If you are not a healthcare professional, please consult your doctor or pharmacist.
France
XALUPRINE
XALUPRINE® is the brand name of mercaptopurine oral suspension indicated for the treatment of acute lymphocytic leukemia. It belongs to a group of medicines called cytotoxics (also called chemotherapy). Cytotoxics work by stopping cancer cells from multiplying. It is specifically developed to facilitate dosing in specific age groups.
UCEDANE
UCEDANE® is an alternative version of the proven niche molecule carglumic acid, with notable differences to the original. This molecule is often used in the treatment of Urea Cycle Disorders (UCD’s).
PHEBURANE
PHEBURANE® is an alternative version of the proven niche molecule phenylbutyrate, with notable differences to the original. This molecule is often used in the treatment of Urea Cycle Disorders (UCD’s).
GRANUPAS
GRANUPAS® is the brand name for the proven molecule para-aminosalicylic acid used as part of an appropriate combination regimen for multi-drug resistant tuberculosis which is quite rare in EU nowadays.
AMSALYO
Amsalyo® is the brand name of amsacrine powder for solution for perfusion. It belongs to a group of medicines called cytotoxics (also called chemotherapy). Cytotoxics work by stopping cancer cells from multiplying.
Turkey
UCEDANE
UCEDANE® is an alternative version of the proven niche molecule carglumic acid, with notable differences to the original. This molecule is often used in the treatment of Urea Cycle Disorders (UCD’s).
European public assessment report
Pharmacovigilance and side effects
For Turkey, you can fill out the TÜFAM notification form and send it to lucanepharma.pv@pleksus.com.tr or call 0 531 280 20 79 for your side effect/adverse reaction report about Lucane Pharma medicines.
Spain
UCEDANE
UCEDANE® is an alternative version of the proven niche molecule carglumic acid, with notable differences to the original. This molecule is often used in the treatment of Urea Cycle Disorders (UCD’s).
PHEBURANE
PHEBURANE® is an alternative version of the proven niche molecule phenylbutyrate, with notable differences to the original. This molecule is often used in the treatment of Urea Cycle Disorders (UCD’s).
GRANUPAS
GRANUPAS® is the brand name for the proven molecule para-aminosalicylic acid used as part of an appropriate combination regimen for multi-drug resistant tuberculosis which is quite rare in EU nowadays.
United Kingdom
UCEDANE
UCEDANE® is an alternative version of the proven niche molecule carglumic acid, with notable differences to the original. This molecule is often used in the treatment of Urea Cycle Disorders (UCD’s).
PHEBURANE
PHEBURANE® is an alternative version of the proven niche molecule phenylbutyrate, with notable differences to the original. This molecule is often used in the treatment of Urea Cycle Disorders (UCD’s).
GRANUPAS
GRANUPAS® is the brand name for the proven molecule para-aminosalicylic acid used as part of an appropriate combination regimen for multi-drug resistant tuberculosis which is quite rare in EU nowadays.
Italy & BENELUX
UCEDANE
UCEDANE® is an alternative version of the proven niche molecule carglumic acid, with notable differences to the original. This molecule is often used in the treatment of Urea Cycle Disorders (UCD’s).
PHEBURANE
PHEBURANE® is an alternative version of the proven niche molecule phenylbutyrate, with notable differences to the original. This molecule is often used in the treatment of Urea Cycle Disorders (UCD’s).
GRANUPAS
GRANUPAS® is the brand name for the proven molecule para-aminosalicylic acid used as part of an appropriate combination regimen for multi-drug resistant tuberculosis which is quite rare in EU nowadays.